PRA Health Sciences Inc
IQVIA Has Fallen 2.9%, but Analysts Are Still on Board
On May 16, IQVIA Holdings’ (IQV) closing price was $99.3, almost 2.9% lower than its closing price on May 15.
IBB’s Mid-Cap Stocks: Kite Pharma Drug Gets Orphan Drug Status
IBB’s mid-cap holding Kite Pharma (KITE) rose by 3.3% on the news of the FDA granting orphan drug status to Kite’s KTE-C19.
Teachers adds a new stake in PRA Health Sciences
PRA Health Sciences is a leading global contract research organization. PRA raised $306 million in its initial public offering in November last year.